当前位置: X-MOL 学术Eur. J. Clin. Microbiol. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Detection of anti-Pneumocystis jirovecii antibodies in human serum using a recombinant synthetic multi-epitope kexin-based antigen.
European Journal of Clinical Microbiology & Infectious Diseases ( IF 4.5 ) Pub Date : 2020-06-16 , DOI: 10.1007/s10096-020-03936-2
Ana Luísa Tomás 1 , Fernando Cardoso 1 , Bruno de Sousa 2 , Olga Matos 1
Affiliation  

Interest in the detection of specific anti-Pneumocystis jirovecii antibodies has emerged as less-invasive alternative diagnostic approaches. Here is presented the performance of an ELISA based on a recombinant synthetic multi-epitope kexin 1 (Kex1) antigen of P. jirovecii, previously developed. Results showed that IgM anti-Kex1 levels were found significantly increased in patients with Pneumocystis pneumonia (PcP) compared with non-PcP cases (p < 0.001), allowing a diagnostic performance of PcP with a 70.8% sensitivity and a 75.0% specificity. These results suggest that this Kex1-based ELISA is a promising tool toward the serodiagnosis of PcP when the standard methods are difficult to perform.



中文翻译:

使用重组合成的基于多表位kexin的抗原检测人血清中的抗肺孢子虫肺炎支原体抗体。

作为侵袭性较低的替代诊断方法,人们对检测特异抗肺孢子虫肺炎支原体抗体的兴趣已经显现。这里提出的ELISA的基于重组合成的多表位可心1(KEX1)抗原的性能P.卡氏肺囊虫,以前开发的。结果表明,与非PcP病例相比,肺炎性囊炎(PcP)患者的IgM抗Kex1水平显着升高(p <0.001),从而诊断PcP具有70.8%的敏感性和75.0%的特异性。这些结果表明,当难以执行标准方法时,这种基于Kex1的ELISA是对PcP进行血清学诊断的有前途的工具。

更新日期:2020-06-16
down
wechat
bug